Molecular carcinogenesis in equine penile cancer: A potential animal model for human penile cancer
Human penile cancer is a rare disease in developed countries with an incidence rate of around 1 per 100,000 [1]. In contrast, it is more common in developing countries accounting for up to 10% to 17% of cancer in males with an incidence that reaches 4 per 100,000 [1,2]. Squamous cell carcinoma (SCC) is the predominant cancer type and accounts for over 95% of penile cancer cases [3 –5]. The main treatment for advanced tumors is phalectomy and, when inguinal lymph node metastasis is present, bilateral inguinal lymphadenectomy is also performed.
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Alejandro Su árez-Bonnet, Claire Willis, Rachel Pittaway, Ken Smith, Tim Mair, Simon L. Priestnall Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Penile Cancer | Rare Diseases | Skin Cancer | Squamous Cell Carcinoma | Urology & Nephrology